Fifty-three organizations began participating April 1 in the first performance year of the , the Center for Medicare and Medicaid Innovation today. Organizations that applied and deferred their start date will start the model on Jan. 1, 2022, if they continue to meet the model鈥檚 requirements, but the agency will not solicit new applications to start in January.
 
鈥淭he Innovation Center is reviewing its portfolio and learning from the implementation of this model to inform next steps on both the GPDC Model and strategies for population health, risk-based models,鈥 the agency said.
 

Related News Articles

Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B 鈥渞ebate鈥
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation鈥
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state鈥檚 340B contract pharmacy law鈥
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies鈥 requests to approve their unlawful 340B rebate models. 鈥淭he 340B鈥
Headline
The House Ways and Means Committee today advanced its portion of the fiscal year 2025 reconciliation bill by a 26-19 vote along party lines, following an hours鈥
Headline
The House Ways and Means Committee May 13 began to mark up its portion of the fiscal year 2025 reconciliation bill, with some proposals impacting the health鈥